News Column

PEREGRINE PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

June 10, 2014

Item 8.01 Other Events.

On June 10, 2014, Peregrine Pharmaceuticals, Inc. (the "Company") issued a press release announcing the declaration by the Company's Board of Directors of a quarterly cash dividend payment of $0.65625 per share (the "Dividend") on the Company's 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock"), accruing from April 1, 2014 through June 30, 2014. The Dividend equates to an annualized 10.50% per share of Series E Preferred Stock based on the $25.00 per share stated liquidation preference. The Dividend on the Series E Preferred Stock is payable on July 1, 2014 to holders of record at the close of business on June 20, 2014. A copy of the press release is filed hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:

Exhibit Number

99.1 Press Release issued June 10, 2014.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters